Cargando…
High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
BACKGROUND: Gadofosveset is a gadolinium-based blood pool contrast agent that was approved by the United States Food and Drug Administration in 2008. Its unanticipated withdrawal from production in 2016 created a void in the blood pool agent inventory and highlighted the need for an alternative agen...
Autores principales: | Shahrouki, Puja, Khan, Sarah N., Yoshida, Takegawa, Iskander, Paul J., Ghahremani, Shahnaz, Finn, J. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857136/ https://www.ncbi.nlm.nih.gov/pubmed/34936018 http://dx.doi.org/10.1007/s00247-021-05225-2 |
Ejemplares similares
-
High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
por: Shahrouki, Puja, et al.
Publicado: (2019) -
Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017) -
Gadofosveset trisodium in coronary magnetic resonance angiography at 3 Tesla
por: Raman, Fabio S, et al.
Publicado: (2014) -
Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
por: Schreinemacher, Marc H., et al.
Publicado: (2012) -
A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
por: Camren, G. Paul, et al.
Publicado: (2014)